CN109452648A - 叶绿素-海藻酸钠微球的制备方法 - Google Patents
叶绿素-海藻酸钠微球的制备方法 Download PDFInfo
- Publication number
- CN109452648A CN109452648A CN201811530733.0A CN201811530733A CN109452648A CN 109452648 A CN109452648 A CN 109452648A CN 201811530733 A CN201811530733 A CN 201811530733A CN 109452648 A CN109452648 A CN 109452648A
- Authority
- CN
- China
- Prior art keywords
- sodium alginate
- chlorophyll
- micro ball
- mixed emulsion
- ball preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000661 sodium alginate Substances 0.000 title claims abstract description 44
- 229940005550 sodium alginate Drugs 0.000 title claims abstract description 44
- 239000011806 microball Substances 0.000 title claims abstract description 18
- 238000002360 preparation method Methods 0.000 title claims abstract description 17
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims abstract description 26
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims abstract description 26
- 235000010413 sodium alginate Nutrition 0.000 claims abstract description 26
- 239000000839 emulsion Substances 0.000 claims abstract description 20
- 235000012680 lutein Nutrition 0.000 claims abstract description 20
- 239000001656 lutein Substances 0.000 claims abstract description 20
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 claims abstract description 20
- 229960005375 lutein Drugs 0.000 claims abstract description 20
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 claims abstract description 20
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 claims abstract description 20
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 claims abstract description 20
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims abstract description 13
- 239000012153 distilled water Substances 0.000 claims abstract description 13
- 235000019359 magnesium stearate Nutrition 0.000 claims abstract description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 13
- 238000003756 stirring Methods 0.000 claims abstract description 11
- 238000009210 therapy by ultrasound Methods 0.000 claims abstract description 3
- 238000003760 magnetic stirring Methods 0.000 claims description 6
- 238000001291 vacuum drying Methods 0.000 claims description 4
- 229930002875 chlorophyll Natural products 0.000 abstract description 2
- 235000019804 chlorophyll Nutrition 0.000 abstract description 2
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 abstract description 2
- 230000002349 favourable effect Effects 0.000 abstract description 2
- 230000000968 intestinal effect Effects 0.000 abstract description 2
- 238000002156 mixing Methods 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- 239000003814 drug Substances 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 241000195493 Cryptophyta Species 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Botany (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明公开一种叶绿素‑海藻酸钠微球的制备方法,包括以下步骤:(1)制备海藻酸钠溶液;(2)向所述海藻酸钠溶液中加入叶黄素、硬脂酸镁、液体石蜡,搅拌,超声处理,再在30MPa的压力下通过高压均质机3次,静置2‑3h,得到混合乳液;(3)将所述混合乳液滴加至处于搅拌状态下的氯化钙溶液中,滴加完毕后,搅拌,抽滤,用蒸馏水洗涤3次,在室温下静置24h后,真空干燥。本发明制备的叶绿素‑海藻酸钠微球微球外观形态圆整,具有多孔性能,分散性良好,易于在结肠pH环境中溶胀释放,稳定性好。
Description
技术领域
本发明属于食品技术领域,具体涉及一种叶绿素-海藻酸钠微球的制备方法。
背景技术
叶黄素是一种天然的类胡萝卜素,色泽鲜艳,着色力强,抗氧化性好,安全无毒害。叶黄素广泛存在于蔬菜、花卉、水果和某些藻类植物中,被应用于食品、保健品、医药等多个领域。美国食品药品监督管理局早在1995年就已批准叶黄素作为食品补充剂。最新的研究结果表明,叶黄素有保护视觉,预防白内障、预防动脉硬化、增强免疫力等功效,此外预防癌变发生、延缓癌症等也是目前科学工作者的研究焦点。
叶黄素属于脂溶性色素,溶于有机溶剂,化学结构中存在多个共轭双键,具有高度不饱和性。叶黄素对光和氧十分敏感,易被氧化降解,溶解性和稳定性低,以上缺点限制了其在药品和食品领域的应用。因此,改善叶黄素这些性质成为其制剂研究的首要问题。
发明内容
针对现有技术的缺陷,本发明提供一种叶绿素-海藻酸钠微球的制备方法,制备的叶绿素-海藻酸钠微球稳定性好。
叶绿素-海藻酸钠微球的制备方法,包括以下步骤:
(1)称取海藻酸钠,加入蒸馏水中,置于磁力搅拌器中,在55-63℃下搅拌15min,形成0.08-0.12g/mL的海藻酸钠溶液;
(2)向所述海藻酸钠溶液中加入叶黄素、硬脂酸镁、液体石蜡,在500rpm的转速下搅拌30-40min,然后超声处理10-15min,再在30MPa的压力下通过高压均质机3次,静置2-3h,得到混合乳液;
(3)将所述混合乳液滴加至处于搅拌状态下的浓度为0.05-0.08g/mL的氯化钙溶液中,滴加完毕后,继续搅拌30-40min,抽滤,用蒸馏水洗涤3次,在室温下静置24h后,真空干燥。
优选地,步骤(2)中所述海藻酸钠溶液、叶黄素、硬脂酸镁、液体石蜡的加入比例为20mL:(0.5-0.8)g:(35-40)mg:(1.5-2)mL。
优选地,所述超声处理的条件为:超声功率400-500W、超声频率45KHz。
优选地,步骤(3)中所述混合乳液与氯化钙溶液的体积比为2:(0.5-1.5)。
优选地,所述真空干燥的条件为:真空干燥温度40-50℃、时间4-6h。
本发明的优点:
本发明制备的叶绿素-海藻酸钠微球微球外观形态圆整,具有多孔性能,分散性良好,其平均粒径为145μm,粒度主要分布在100~199μm范围内,易于在结肠pH环境中溶胀释放,稳定性好。
具体实施方式
实施例1
叶绿素-海藻酸钠微球的制备方法,包括以下步骤:
(1)称取海藻酸钠,加入蒸馏水中,置于磁力搅拌器中,在55℃下搅拌15min,形成0.08g/mL的海藻酸钠溶液;
(2)按照海藻酸钠溶液、叶黄素、硬脂酸镁、液体石蜡的加入比例为20mL:0.5g:35mg:1.5mL,向所述海藻酸钠溶液中加入叶黄素、硬脂酸镁、液体石蜡,在500rpm的转速下搅拌30min,然后在超声功率400W、超声频率45KHz的条件下超声处理15min,再在30MPa的压力下通过高压均质机3次,静置2h,得到混合乳液;
(3)按照所述混合乳液与氯化钙溶液的体积比为2:0.5,将所述混合乳液滴加至处于搅拌状态下的浓度为0.05g/mL的氯化钙溶液中,滴加完毕后,继续搅拌30min,抽滤,用蒸馏水洗涤3次,在室温下静置24h后,在40℃下真空干燥6h。
实施例2
叶绿素-海藻酸钠微球的制备方法,包括以下步骤:
(1)称取海藻酸钠,加入蒸馏水中,置于磁力搅拌器中,在63℃下搅拌15min,形成0.12g/mL的海藻酸钠溶液;
(2)按照海藻酸钠溶液、叶黄素、硬脂酸镁、液体石蜡的加入比例为20mL:0.8g:40mg:2mL,向所述海藻酸钠溶液中加入叶黄素、硬脂酸镁、液体石蜡,在500rpm的转速下搅拌40min,然后在超声功率500W、超声频率45KHz的条件下超声处理10min,再在30MPa的压力下通过高压均质机3次,静置3h,得到混合乳液;
(3)按照所述混合乳液与氯化钙溶液的体积比为2:1.5,将所述混合乳液滴加至处于搅拌状态下的浓度为0.08g/mL的氯化钙溶液中,滴加完毕后,继续搅拌40min,抽滤,用蒸馏水洗涤3次,在室温下静置24h后,在50℃下真空干燥4h。
实施例3
叶绿素-海藻酸钠微球的制备方法,包括以下步骤:
(1)称取海藻酸钠,加入蒸馏水中,置于磁力搅拌器中,在58℃下搅拌15min,形成0.1g/mL的海藻酸钠溶液;
(2)按照海藻酸钠溶液、叶黄素、硬脂酸镁、液体石蜡的加入比例为20mL:0.6g:38mg:1.8mL,向所述海藻酸钠溶液中加入叶黄素、硬脂酸镁、液体石蜡,在500rpm的转速下搅拌35min,然后在超声功率450W、超声频率45KHz的条件下超声处理12min,再在30MPa的压力下通过高压均质机3次,静置2h,得到混合乳液;
(3)按照所述混合乳液与氯化钙溶液的体积比为2:0.8,将所述混合乳液滴加至处于搅拌状态下的浓度为0.06g/mL的氯化钙溶液中,滴加完毕后,继续搅拌35min,抽滤,用蒸馏水洗涤3次,在室温下静置24h后,在45℃下真空干燥5h。
实施例4
叶绿素-海藻酸钠微球的制备方法,包括以下步骤:
(1)称取海藻酸钠,加入蒸馏水中,置于磁力搅拌器中,在60℃下搅拌15min,形成0.1g/mL的海藻酸钠溶液;
(2)按照海藻酸钠溶液、叶黄素、硬脂酸镁、液体石蜡的加入比例为20mL:0.8g:39 mg:1.8mL,向所述海藻酸钠溶液中加入叶黄素、硬脂酸镁、液体石蜡,在500rpm的转速下搅拌35min,然后在超声功率500W、超声频率45KHz的条件下超声处理15min,再在30MPa的压力下通过高压均质机3次,静置2h,得到混合乳液;
(3)按照所述混合乳液与氯化钙溶液的体积比为2:1.2,将所述混合乳液滴加至处于搅拌状态下的浓度为0.06g/mL的氯化钙溶液中,滴加完毕后,继续搅拌40min,抽滤,用蒸馏水洗涤3次,在室温下静置24h后,在40℃下真空干燥4h。
Claims (5)
1.叶绿素-海藻酸钠微球的制备方法,其特征在于:包括以下步骤:
(1)称取海藻酸钠,加入蒸馏水中,置于磁力搅拌器中,在55-63℃下搅拌15min,形成0.08-0.12g/mL的海藻酸钠溶液;
(2)向所述海藻酸钠溶液中加入叶黄素、硬脂酸镁、液体石蜡,在500rpm的转速下搅拌30-40min,然后超声处理10-15min,再在30MPa的压力下通过高压均质机3次,静置2-3h,得到混合乳液;
(3)将所述混合乳液滴加至处于搅拌状态下的浓度为0.05-0.08g/mL的氯化钙溶液中,滴加完毕后,继续搅拌30-40min,抽滤,用蒸馏水洗涤3次,在室温下静置24h后,真空干燥。
2.根据权利要求1所述叶绿素-海藻酸钠微球的制备方法,其特征在于:步骤(2)中所述海藻酸钠溶液、叶黄素、硬脂酸镁、液体石蜡的加入比例为20mL:(0.5-0.8)g:(35-40)mg:(1.5-2)mL。
3.根据权利要求1所述叶绿素-海藻酸钠微球的制备方法,其特征在于:所述超声处理的条件为:超声功率400-500W、超声频率45KHz。
4.根据权利要求1所述叶绿素-海藻酸钠微球的制备方法,其特征在于:步骤(3)中所述混合乳液与氯化钙溶液的体积比为2:(0.5-1.5)。
5.根据权利要求1所述叶绿素-海藻酸钠微球的制备方法,其特征在于:所述真空干燥的条件为:真空干燥温度40-50℃、时间4-6h。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811530733.0A CN109452648A (zh) | 2018-12-14 | 2018-12-14 | 叶绿素-海藻酸钠微球的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811530733.0A CN109452648A (zh) | 2018-12-14 | 2018-12-14 | 叶绿素-海藻酸钠微球的制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN109452648A true CN109452648A (zh) | 2019-03-12 |
Family
ID=65613291
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811530733.0A Pending CN109452648A (zh) | 2018-12-14 | 2018-12-14 | 叶绿素-海藻酸钠微球的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109452648A (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2022155792A1 (zh) * | 2021-01-19 | 2022-07-28 | 江苏省农业科学院 | 负载叶黄素的海藻酸钠基水凝胶及其制备方法和用途 |
CN115282128A (zh) * | 2022-08-02 | 2022-11-04 | 上海弗艾柏生物科技有限公司 | 猫面部信息素凝胶球及其制备方法 |
-
2018
- 2018-12-14 CN CN201811530733.0A patent/CN109452648A/zh active Pending
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2022155792A1 (zh) * | 2021-01-19 | 2022-07-28 | 江苏省农业科学院 | 负载叶黄素的海藻酸钠基水凝胶及其制备方法和用途 |
CN115282128A (zh) * | 2022-08-02 | 2022-11-04 | 上海弗艾柏生物科技有限公司 | 猫面部信息素凝胶球及其制备方法 |
CN115282128B (zh) * | 2022-08-02 | 2024-03-19 | 上海弗艾柏生物科技有限公司 | 猫面部信息素凝胶球及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105054070A (zh) | 一种白刺花色苷粗提物及其微胶囊 | |
CN109452648A (zh) | 叶绿素-海藻酸钠微球的制备方法 | |
CN106075472B (zh) | 具有荧光示踪功能的壳聚糖基衍生物聚合物点的制备方法 | |
CN101991175B (zh) | 一种高顺式异构体含量的番茄红素微乳制剂产品及制备方法 | |
CN106075437B (zh) | 一种近红外光激发实时监控释药的核壳结构药物载体的制备方法 | |
CN107362394A (zh) | 一种带止血功能的注射器针管及其制备方法 | |
CN107510842A (zh) | 一种洁净且具有优良光热效果的复合光热剂的制备方法 | |
CN112655952A (zh) | 一种虾青素藻油高内相乳液及其制备方法 | |
CN112159342A (zh) | 氨基酸类天然低共熔溶剂提取虾壳中虾青素的方法 | |
CN103980434B (zh) | 一种两亲性聚合物、其制备方法、复合纳米药物载体及其制备方法 | |
CN102356838A (zh) | 一种叶黄素微胶囊制剂及其制备方法 | |
CN107981355A (zh) | 一种番茄红素微胶囊的制备方法 | |
CN107715169B (zh) | 含plga纳米微粒的海藻酸钠载药复合栓塞微球的制备方法及产品 | |
Feng et al. | Effect of V-type crystallinity and starch particle structure on the oil loading capacity and anti-oxidation | |
CN103549635B (zh) | 基于金属有机骨架的抗性淀粉营养载体的制备方法及产品 | |
CN104017319B (zh) | 一种对紫外光具有光响应特性的高分子水凝胶 | |
CN103990185B (zh) | 一种卡拉胶和明胶微球栓塞剂及其制备方法 | |
CN103601894B (zh) | 一种表面接枝壳聚糖的交联聚丙烯酸树脂珠及其制备方法 | |
CN109865141B (zh) | 一种通过压力合成抗癌药物/MOFs复合功能材料的方法 | |
Das et al. | Biocompatible amphiphilic microgel derived from dextrin and poly (methyl methacrylate) for dual drugs carrier | |
Chen et al. | Recent advance in chemistry modified methods of natural polysaccharides and their applications | |
CN114225094A (zh) | 含纳米碳酸钙的明胶复合栓塞微球、其制备方法及载药栓塞微球 | |
CN113680289A (zh) | 纳米纤维素-酚型抗氧化凝胶及其稳定的Pickering高内相乳液 | |
CN110613135A (zh) | 一种负载番茄红素的纳米载体、制备方法及应用 | |
CN108236736A (zh) | 一种可载化疗药表柔比星的聚乙烯醇栓塞微球的合成方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20190312 |